Subscribe

Policy & Regulation Today - October 13, 2026

Daily policy & regulation roundup: 6 stories curated October 13, 2026. Lead: fda proposes restrictions on compounding bulk popular weight loss drugs.

Policy & Regulation Today - October 13, 2026

The latest in policy & regulation: 6 developments from the past day, tracked and curated by the HealthTech Cube news desk. The lead story: fda proposes restrictions on compounding bulk popular weight loss drugs.

fda proposes restrictions on compounding bulk popular weight loss drugs

Olhar Digital2026-10-12

Health care leaders are planning around Medicare's ACCESS model but doubt it will pay off

Medical Economics2026-10-12

Electronic prior auths are coming. Here’s what physicians must ask their EHR and billing vendors

Medical Economics2026-10-12

CMS, GAO Reports Offer Early Look at Rural Health Funding and Oversight

HCI Innovation Group2026-10-12

Why Calling ICD-10 a Diagnosis Is Healthcare’s Costliest Design Flaw

Healthcare software colleagues of mine often describe a recurring discussion they have with their outsourced development teams. They recount that when they try to explain the difference between a billing diagnosis and a clinical diagnosis, the engineers on the other end deliver a common platitude: “a diagnosis is a diagnosis.”  That answer is defensible in ... Read More

hitconsultant.net2026-10-12

health news today weight loss drugs

Olhar Digital2026-10-12

Follow the full firehose on the HTC Wire, refreshed automatically every day.

Reach the people behind these stories. HealthTech Cube demand gen programs deliver qualified healthcare technology leads from $49.50 per lead - see packages or download the 2026 media kit.